Search clinical trials for: ChimeriVax™-JE Vaccine

Total 9967 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Prevenar in High-Risk Children

Pneumococcal Disease

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Vaccine in Adults With HIV

HIV Infections

Germany, United States, Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

Meningitis, Meningococcal

Australia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Vaccine in Adults With HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Virus Diseases | Influenza

United States
Sinovac Biotech Co., Ltd
Ministry of Science and Technology of the People´s Republic of China

Completed

Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects

Influenza

China
Sinovac Biotech Co., Ltd
Centers for Disease Control and Prevention, China

Completed

Safety and Immunogenicity of an Inactivated Pandemic Influenza Vaccine

Prevention | Pandemic Influenza
Sinovac Biotech Co., Ltd

Completed

Phase IV Clinical Trial of an Influenza Split Vaccine Anflu

Influenza
Handok Inc.

Completed

Fexofenadine in Pruritic Skin Disease

Pruritus

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

HIV Infections

United States
Queen Elizabeth II Health Sciences Centre

Unknown

The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients

Pertussis
Institute of Cardiology, Warsaw, Poland
Solvay Pharmaceuticals

Completed

Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

Coronary Artery Disease

Poland
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust; Walter Reed Army Institute of Research...

Completed

Sporozoite Challenge of Polyprotein Vaccinees

Malaria | Malaria, Falciparum

United Kingdom
Mount Sinai Hospital, Canada
Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Canadian Foundation...

Completed

A Randomized Controlled Trial of a Mindfulness-Based Stress Reduction Intervention for Men Living With HIV

HIV Infections

Canada
Bristol-Myers Squibb

Completed

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

HIV Infections

United States
National Cancer Institute (NCI)

Completed

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Multiple Myeloma | Graft vs Host Disease

United States
Centers for Disease Control and Prevention
United States Agency for International Development (USAID); Bill and Melinda... and other collaborators

Unknown

Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn

Sepsis | Infant, Newborn, Diseases | Puerperal Infection

South Africa
Centers for Disease Control and Prevention
Alaska Native Medical Center

Completed

VaxTeen Hepatitis B Vaccine Booster Study

Hepatitis

United States
Cytos Biotechnology AG

Completed

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

Hypersensitivity

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Melanoma

Germany
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Malignant Melanoma

Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

Determining an Effective Site (Groin Versus Arm) for Giving HIV Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Unknown

Resistance to HIV Infection

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of Immune Responses to HIV Vaccines

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Institute of Allergy and Infectious Diseases...

Completed

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluation of the Safety of and Immune Response to an HIV Vaccine in Healthy Adults

HIV Infections

Australia
José Mordoh, M.D., Ph.D.

Completed

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Melanoma

Argentina
European Malaria Vaccine Initiative

Unknown

GMZ2-Aluminum Hydroxide Phase I, Tübingen

Malaria

Germany
Norwegian Institute of Public Health

Completed

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Pertussis | Tetanus | Diphtheria | Polio

Norway
GlaxoSmithKline

Completed

Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)

Hepatitis B Disease

Belgium
MedImmune LLC

Completed

Study To Evaluate the Safety of Bivalent Vaccine

Healthy

United States
HaEmek Medical Center, Israel

Completed

The Effectiveness of Influenza Vaccine Among Health Care Workers in a Hospital Setting.

Influenza Vaccines

Israel
University of Oxford

Completed

Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.

Tuberculosis

United Kingdom
University of Oxford

Completed

A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers

TB

United Kingdom
MedImmune LLC

Completed

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Healthy | Influenza

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Trial of Modafinil for Methamphetamine Dependence

Amphetamine Dependence

Australia
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
Tel-Aviv Sourasky Medical Center

Terminated

The Effect of Rituximab on the Humoral Response to Influenza Vaccine

Rheumatoid Arthritis
Medical University of Vienna

Completed

Vasoactive Intestinal Peptide in COPD (VIPCOPD)

Pulmonary Hypertension | COPD
St. Joseph's Health Care London

Completed

Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients

Hepatitis B

Canada
Seoul National University Hospital
HK inno.N Corporation

Completed

Safety and Immunogenicity of CJ-50300

Smallpox

Korea, Republic of
Centers for Disease Control and Prevention
Southcentral Foundation; Alaska Native Tribal Health Consortium

Completed

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Pneumococcal Infections

United States
Centers for Disease Control and Prevention
Johns Hopkins University; University of Pittsburgh; Maryland Department of Health... and other collaborators

Completed

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Meningitis
French National Agency for Research on AIDS and...

Completed

Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers

HIV Infections | HIV Seronegativity

France
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Influenza

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Pandemic Influenza Disease

Italy
Novartis
Novartis Vaccines

Completed

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Encephalitis, Tick-Borne

Germany
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Prevention of Meningococcal Infection

Italy
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust

Completed

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Malaria | Malaria, Falciparum

United Kingdom

Search clinical trials for: ChimeriVax™-JE Vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations